Trial Information
Quality of Life in Lung Cancer Survivors
Inclusion Criteria:
- Diagnosis of primary Stage IA or IB NSCLC;
- Underwent surgical resection for NSCLC at MSKCC;
- From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment;
- No evidence of disease (NED) at the time of recruitment;
- Can be reached by telephone;
- Able to provide informed consent.
Exclusion Criteria:
- Undergoing active antineoplastic treatment;
- Major psychopathology or cognitive impairment likely in the judgment of the
investigator to interfere with participation and compliance with the protocol.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.
Outcome Time Frame:
conclusion of study
Safety Issue:
No
Principal Investigator
Jamie Ostroff, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
05-057
NCT ID:
NCT00586937
Start Date:
June 2005
Completion Date:
June 2013
Related Keywords:
- Lung Cancer Survivors
- Lung Cancer Survivors
- Lung Neoplasms
Name | Location |
Memorial Sloan Kettering Cancer Center |
New York, New York 10021 |